ZNF391
gene geneOn this page
Also known as dJ153G14.3
Summary
ZNF391 (zinc finger protein 391, HGNC:18779) is a protein-coding gene on chromosome 6p22.1, encoding Zinc finger protein 391 (Q9UJN7). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 346157 — RefSeq curated summary.
At a glance
- GWAS associations: 21
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_001076781
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18779 |
| Approved symbol | ZNF391 |
| Name | zinc finger protein 391 |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ153G14.3 |
| Ensembl gene | ENSG00000124613 |
| Ensembl biotype | protein_coding |
| Entrez | 346157 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 8 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000244576, ENST00000461521, ENST00000477999, ENST00000482767, ENST00000901127, ENST00000901128, ENST00000901129, ENST00000937720, ENST00000937721, ENST00000958924
RefSeq mRNA: 4 — MANE Select: NM_001076781
NM_001076781, NM_001322288, NM_001322289, NM_001322293
CCDS: CCDS43429
Canonical transcript exons
ENST00000244576 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001426539 | 27388759 | 27389075 |
| ENSE00001537391 | 27399442 | 27399550 |
| ENSE00001733042 | 27400293 | 27403908 |
Expression profiles
Bgee: expression breadth ubiquitous, 166 present calls, max score 84.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.2089 / max 65.0649, expressed in 938 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66567 | 0.8998 | 469 |
| 66570 | 0.8979 | 502 |
| 66568 | 0.2293 | 110 |
| 66569 | 0.1557 | 80 |
| 66566 | 0.0262 | 7 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.35 | gold quality |
| right uterine tube | UBERON:0001302 | 79.40 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.09 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 73.84 | gold quality |
| prefrontal cortex | UBERON:0000451 | 73.79 | gold quality |
| cerebellar cortex | UBERON:0002129 | 73.77 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 73.76 | gold quality |
| body of pancreas | UBERON:0001150 | 73.42 | gold quality |
| left ovary | UBERON:0002119 | 73.25 | gold quality |
| right ovary | UBERON:0002118 | 72.79 | gold quality |
| cortical plate | UBERON:0005343 | 72.70 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.49 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 72.44 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 71.87 | gold quality |
| cingulate cortex | UBERON:0003027 | 71.77 | gold quality |
| ventricular zone | UBERON:0003053 | 71.44 | gold quality |
| cerebellum | UBERON:0002037 | 71.27 | gold quality |
| pancreas | UBERON:0001264 | 71.10 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 71.02 | gold quality |
| endocervix | UBERON:0000458 | 70.99 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 70.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 70.86 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.71 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 70.63 | gold quality |
| left testis | UBERON:0004533 | 70.62 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 70.61 | gold quality |
| right testis | UBERON:0004534 | 70.57 | gold quality |
| right coronary artery | UBERON:0001625 | 70.53 | gold quality |
| ganglionic eminence | UBERON:0004023 | 70.46 | gold quality |
| nucleus accumbens | UBERON:0001882 | 70.41 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.86 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
118 targeting ZNF391, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-223-3P | 99.99 | 70.14 | 1140 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
Literature-anchored findings (GeneRIF, showing 1)
- Spatial Expression Pattern of ZNF391 Gene in the Brains of Patients With Schizophrenia, Bipolar Disorders or Major Depressive Disorder Identifies New Cross-Disorder Biotypes: A Trans-Diagnostic, Top-Down Approach. (PMID:33822213)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 391 — Q9UJN7 (reviewed: Q9UJN7)
All UniProt accessions (2): C9JUF8, Q9UJN7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (4): NP_001070249, NP_001309217, NP_001309218, NP_001309222 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (17 total): zinc finger region 9, compositionally biased region 3, region of interest 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UJN7-F1 | 76.74 | 0.65 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 81 (showing top):
BROWNE_HCMV_INFECTION_12HR_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, ALKBH3_TARGET_GENES, ARNT2_TARGET_GENES, CBX5_TARGET_GENES, CHAMP1_TARGET_GENES, CREB3L4_TARGET_GENES, DIDO1_TARGET_GENES, GLI4_TARGET_GENES, HES2_TARGET_GENES, HMG20B_TARGET_GENES, KLF14_TARGET_GENES, KLF7_TARGET_GENES, RLF_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
244 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF391 | KRABD4 | Q5JUW0 | 638 |
| ZNF391 | OR2H1 | Q9GZK4 | 574 |
| ZNF391 | SAPCD1 | Q5SSQ6 | 542 |
| ZNF391 | LRRC36 | Q1X8D7 | 400 |
| ZNF391 | SPRYD4 | Q8WW59 | 399 |
| ZNF391 | C5orf34 | Q96MH7 | 399 |
| ZNF391 | GBX1 | Q14549 | 358 |
| ZNF391 | MRPS11 | P82912 | 356 |
| ZNF391 | CALHM2 | Q9HA72 | 349 |
| ZNF391 | ABHD3 | Q8WU67 | 335 |
| ZNF391 | NELFE | P18615 | 323 |
| ZNF391 | TMEM178A | Q8NBL3 | 322 |
| ZNF391 | MRPL42 | Q9Y6G3 | 320 |
| ZNF391 | PNPLA7 | Q6ZV29 | 314 |
| ZNF391 | SLC25A26 | Q70HW3 | 311 |
| ZNF391 | PTOV1 | Q86YD1 | 311 |
IntAct
0 interactions, top by confidence:
BioGRID (8): ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Two-hybrid), ZNF391 (Affinity Capture-MS), ZNF391 (Affinity Capture-MS), ZNF391 (Affinity Capture-MS)
ESM2 similar proteins: A0JNB1, A6QLU5, O75123, O75820, P10076, P10755, P16374, P17031, P17097, P17141, P51814, Q02975, Q08ER8, Q14588, Q14590, Q32KN0, Q3V080, Q4V8A8, Q5CZA5, Q5R4K8, Q5R5Q6, Q5R9S5, Q5RBX0, Q61751, Q6GQR8, Q6P560, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q7Z3V5, Q8BLB0, Q8N141, Q8N184, Q8N823, Q8N8J6, Q8N9F8, Q8TBZ5, Q8TF47, Q96ND8
Diamond homologs: A0A087WUV0, Q96K75, Q99676, Q9HBT8, Q9UJL9, Q9UJN7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
600 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:27397583:G:GG | donor_gain | 0.9800 |
| 6:27397582:A:AG | donor_gain | 0.9700 |
| 6:27400292:GATA:G | acceptor_gain | 0.9700 |
| 6:27388877:G:GT | donor_gain | 0.9500 |
| 6:27399551:G:GG | donor_gain | 0.9500 |
| 6:27399547:CTTGG:C | donor_loss | 0.9400 |
| 6:27399548:TTGGT:T | donor_loss | 0.9400 |
| 6:27399549:TGGTG:T | donor_loss | 0.9400 |
| 6:27399551:GT:G | donor_loss | 0.9400 |
| 6:27399552:T:TA | donor_loss | 0.9400 |
| 6:27399553:GAGTA:G | donor_loss | 0.9400 |
| 6:27399554:AG:A | donor_loss | 0.9400 |
| 6:27399555:G:A | donor_loss | 0.9400 |
| 6:27388983:T:TA | donor_gain | 0.9200 |
| 6:27399436:CTGCA:C | acceptor_loss | 0.9200 |
| 6:27399437:TGCA:T | acceptor_loss | 0.9200 |
| 6:27399438:GCAGG:G | acceptor_loss | 0.9200 |
| 6:27399439:CA:C | acceptor_loss | 0.9200 |
| 6:27399440:A:G | acceptor_loss | 0.9200 |
| 6:27399441:G:C | acceptor_loss | 0.9200 |
| 6:27400287:TTTCA:T | acceptor_loss | 0.9200 |
| 6:27400288:TTCA:T | acceptor_loss | 0.9200 |
| 6:27400289:TCAGA:T | acceptor_loss | 0.9200 |
| 6:27400291:AG:A | acceptor_loss | 0.9200 |
| 6:27388925:TTCG:T | donor_gain | 0.9100 |
| 6:27388984:T:A | donor_gain | 0.9100 |
| 6:27399556:T:G | donor_loss | 0.9100 |
| 6:27389043:GGTG:G | donor_loss | 0.9000 |
| 6:27389044:G:GA | donor_loss | 0.9000 |
| 6:27389045:T:TT | donor_loss | 0.9000 |
AlphaMissense
2387 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:27400890:T:C | F174L | 0.998 |
| 6:27400892:T:A | F174L | 0.998 |
| 6:27400892:T:G | F174L | 0.998 |
| 6:27400974:T:C | F202L | 0.998 |
| 6:27400976:T:A | F202L | 0.998 |
| 6:27400976:T:G | F202L | 0.998 |
| 6:27400806:T:C | F146L | 0.997 |
| 6:27400808:C:A | F146L | 0.997 |
| 6:27400808:C:G | F146L | 0.997 |
| 6:27401310:T:C | F314L | 0.996 |
| 6:27401312:C:A | F314L | 0.996 |
| 6:27401312:C:G | F314L | 0.996 |
| 6:27401394:T:C | F342L | 0.996 |
| 6:27401396:C:A | F342L | 0.996 |
| 6:27401396:C:G | F342L | 0.996 |
| 6:27400897:G:C | R176P | 0.995 |
| 6:27401142:T:C | F258L | 0.995 |
| 6:27401144:C:A | F258L | 0.995 |
| 6:27401144:C:G | F258L | 0.995 |
| 6:27400825:T:C | L152P | 0.994 |
| 6:27400981:G:C | R204P | 0.994 |
| 6:27400993:T:C | L208P | 0.994 |
| 6:27401003:T:A | H211Q | 0.994 |
| 6:27401003:T:G | H211Q | 0.994 |
| 6:27400813:G:C | R148P | 0.993 |
| 6:27400835:T:A | H155Q | 0.993 |
| 6:27400835:T:G | H155Q | 0.993 |
| 6:27400891:T:C | F174S | 0.993 |
| 6:27401008:G:C | R213P | 0.993 |
| 6:27401058:T:C | F230L | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000018252 (6:27372807 G>A), RS1000164453 (6:27401337 C>T), RS1000220226 (6:27388971 A>G,T), RS1000263524 (6:27393621 C>T), RS1000308850 (6:27402091 G>C), RS1000335921 (6:27381519 G>A,T), RS1000337516 (6:27393988 T>C), RS1000841722 (6:27381188 G>A), RS1001096943 (6:27374969 T>A), RS1001384925 (6:27388209 A>G), RS1001427217 (6:27374665 C>G), RS1001566301 (6:27402843 C>T), RS1001572538 (6:27378583 C>T), RS1001580246 (6:27403671 T>G), RS1001663818 (6:27397067 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
21 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_116 | Autism spectrum disorder or schizophrenia | 3.000000e-16 |
| GCST004521_166 | Autism spectrum disorder or schizophrenia | 4.000000e-24 |
| GCST004521_254 | Autism spectrum disorder or schizophrenia | 6.000000e-11 |
| GCST004521_57 | Autism spectrum disorder or schizophrenia | 1.000000e-20 |
| GCST004521_69 | Autism spectrum disorder or schizophrenia | 8.000000e-24 |
| GCST004521_73 | Autism spectrum disorder or schizophrenia | 8.000000e-11 |
| GCST006948_35 | Feeling nervous | 5.000000e-08 |
| GCST008921_6 | Asthma and major depressive disorder | 1.000000e-09 |
| GCST008921_9 | Asthma and major depressive disorder | 3.000000e-08 |
| GCST010002_50 | Refractive error | 4.000000e-34 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
| GCST90011899_28 | Aspartate aminotransferase levels | 8.000000e-30 |
| GCST90011900_180 | Serum alkaline phosphatase levels | 1.000000e-10 |
| GCST90016674_15 | Liver iron content | 2.000000e-29 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009597 | feeling nervous measurement |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
| EFO:0004736 | aspartate aminotransferase measurement |
| EFO:0004533 | alkaline phosphatase measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation, decreases expression, affects cotreatment, increases abundance, increases expression | 3 |
| Valproic Acid | decreases expression | 3 |
| bisphenol A | decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | affects cotreatment, decreases methylation | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Fulvestrant | decreases methylation, affects cotreatment | 1 |
| Acetaminophen | decreases expression | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Tetrachlorodibenzodioxin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD24 | HEK293 eGFP-ZNF391 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.